Back to the main directory
Press Release
- Holding(s) in Company by EQS Group AG
- Aurora Spine Announces FDA 510(k) Clearance for the AERO™ Facet Fusion System by GlobeNewsWire
- Nyt medlem af koncerndirektionen by GlobeNewsWire
- FTI Technology Launches IQ.AI for Review to Accelerate High-Stakes Discovery and Investigations by GlobeNewsWire
- Credit Union 1 Selects nCino to Power True Omnichannel Experience for Members by GlobeNewsWire
- ADN Telecom signs multi-year Telesat Lightspeed partnership agreement by GlobeNewsWire
- CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update by GlobeNewsWire
- Relmada Therapeutics Licenses Phase 2 Bladder Cancer Candidate, NDV-01, from Trigone Pharma, Ltd. by GlobeNewsWire
- Jayud Global Logistics Launches Exclusive Chartered Air Cargo Service Between Fuzhou and Jakarta by GlobeNewsWire
- VRANKEN-POMMERY MONOPOLE : nombre total de droits de vote et d'actions au 28.02.2025 by GlobeNewsWire
- Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results by GlobeNewsWire
- Danske Bank A/S, transactions by persons discharging managerial responsibilities by GlobeNewsWire
- Competition Authority approved new water prices to be applied by Tallinna Vesi by GlobeNewsWire
- PDS Biotech Leadership to Present at 2025 CAGLA NeauxCancer Conference by GlobeNewsWire
- EngageLab Upgrades Its Marketing Automation Functions with AI-Powered Features to Drive Customer Success by GlobeNewsWire
- Celebrated Baker & YouTube Creator Gemma Stafford Partners with Xcel Brands to Bring Bakeware and Home Essentials to Market by GlobeNewsWire
- CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders (AP/PD™) by GlobeNewsWire
- Snail, Inc. to Report Fourth Quarter & Full Year 2024 Financial Results by GlobeNewsWire
- Phillips Edison & Company Inc. Invites You to Join Its First Quarter 2025 Earnings Conference Call by GlobeNewsWire
- Indaptus Therapeutics Chief Medical Officer Roger Waltzman, M.D., M.B.A. to Moderate Panel at CMO360 Summit by GlobeNewsWire
- Mineralys Therapeutics to Host KOL Call to Discuss Clinical Data from Launch-HTN and Advance-HTN Pivotal Trials Tuesday, April 1, 2025, at 8:00 AM ET by GlobeNewsWire
- LM Funding America Announces Fourth Quarter and Full Year 2024 Earnings Call for March 31, 2025 by GlobeNewsWire
- First Patient Dosed in Immutep’s TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer by GlobeNewsWire
- H&R Block names Phillip Miller as Chief Information Security Officer by GlobeNewsWire
- Save the Date: Profound Medical to Host Investor Event at AUA 2025 by GlobeNewsWire